Boxes of tablets, produced by Teva Pharmaceutical Industries Ltd., sit on a pharmacy counter in this arranged photograph in London, U.K., on Thursday, Dec. 29, 2016. The rapid pace of innovation among drugmakers may continue to be overshadowed by broader investment themes, such as the switch away from defensive stocks into more cyclical industries, during 2017, according to Bloomberg Intelligence. Photographer: Chris Ratcliffe/Bloomberg via Getty Images
Phillip Frost, billionaire and chairman of Teva Pharmaceutical Industries Ltd., pauses at the Tel Aviv Stock Exchange in Tel Aviv, Israel, on Wednesday, Aug. 21, 2013. Frost was at the Tel Aviv Stock Exchange to mark the listing of Opko Health Inc., of which he is the largest shareholder. Photographer: Ariel Jerozolimski/Bloomberg via Getty Images
JERUSALEM, ISRAEL - JULY 08: The company Teva Pharmaceutical is the third largest of its kind in the world, is the world market leader amongst the producers of generic medicinal products and is pictured here on July 08, 2013 in Jerusalem, Israel. (Photo by Thomas Koehler/Photothek via Getty Images)
JERUSALEM, ISRAEL - JULY 08: The company Teva Pharmaceutical is the third largest of its kind in the world, is the world market leader amongst the producers of generic medicinal products and is pictured here on July 08, 2013 in Jerusalem, Israel. (Photo by Thomas Koehler/Photothek via Getty Images)
Teva Pharmaceutical Industires Ltd. Sildenafil tablets, the generic name for the drug Viagra, are separated in this arranged photograph at a Walgreens Boots Alliance Inc. store in New York, U.S., on Tuesday, Dec. 12, 2017. Pfizer Inc., which delivered Viagra to the world in 1998, and Teva Pharmaceutical Industries Ltd., the world's largest maker of copycat drugs, are vying to cash in now that the blockbuster drug has lost its patent protection. Photographer: David Williams/Bloomberg via Getty Images
